Stay updated on KN026 in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the KN026 in Metastatic Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedA government funding status notice and an NIH operating status banner were added, and the site revision note was updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check14 days agoChange DetectedIntroduced Show glossary option and Revision: v3.4.0. Updated the QC-related label to 'Last Update Submitted that Met QC Criteria' and standardized capitalization for No FEAR Act data.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe last known status line now indicates Jiangsu Alphamab Biopharmaceuticals Co., Ltd as of September 2023, with status marked as Verified and Unknown.SummaryDifference0.4%

- Check49 days agoChange DetectedAdded Heilongjiang as a Location (Harbin, Heilongjiang, China) and removed the prior Heilongjiang Locations entry; page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check71 days agoChange DetectedThe page revision metadata now shows v3.3.2 as the current revision, replacing v3.3.1. No substantive content or study details appear to be affected.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now shows Revision: v3.3.1, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to KN026 in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.